CAMLINFINE NSE filing

Camlin Fine Sciences Ltd. Announces 33rd AGM on August 11, 2026

The RealCase readLow impact Neutral

Camlin Fine Sciences Limited will hold its 33rd Annual General Meeting on August 11, 2026, at 10:00 AM IST via Video Conferencing. The AGM notice and Annual Report 2025-26 will be distributed electronically to registered members.

Why it matters

The announcement is about a routine annual general meeting, which is a standard corporate procedure and is unlikely to have a material impact on the company's stock price or operations.

The market read

The announcement is a routine corporate event (AGM) and does not contain any new financial information or significant business updates that would sway the sentiment.

Camlin Fine Sciences Limited has announced that its 33rd Annual General Meeting (AGM) will be held on Tuesday, August 11, 2026, at 10:00 AM IST. The meeting will be conducted through Video Conferencing (VC) / Other Audio Visual Means (OAVM) to discuss the businesses outlined in the AGM Notice.

In compliance with applicable provisions of the Companies Act, 2013, and SEBI regulations, the Notice of the AGM along with the Annual Report 2025-26 will be sent electronically to members whose email addresses are registered with the Company, Registrar & Transfer Agents (RTA), or Depository Participants (DPs). Members who have not registered their email addresses will receive a letter providing a weblink to access the Annual Report for FY 2025-26 on the Company's website. Physical copies of the Annual Report can be requested by members by emailing secretaria@camlinfs.com, providing their Folio No. / DP ID and Client ID.

Members will have the opportunity to cast their vote remotely on the businesses set out in the AGM Notice through an electronic voting system. Details regarding remote voting for different shareholding modes will be available in the AGM Notice and on the websites of NSDL, the Company, and the Stock Exchanges. Members attending the Meeting through VC/OAVM will be counted for the purpose of reckoning the quorum.

Filing to action

What to do with a filing like this

Camlin Fine Sciences Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Camlin Fine Sciences Limited. Read the original for the full detail.

View original filing